A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)

被引：4
|
作者：
Teke, Martha E. [1 ]
Sarvestani, Amber Leila [1 ]
Hernandez, Jonathan M. [1 ]
Fernando, Hiran C. [2 ]
Timmerman, Robert D. [3 ]
机构：
[1] NCI, Surg Oncol Program, NIH, Bethesda, MD 20892 USA
[2] Allegheny Hlth Network, Div Thorac Surg, Dept Thorac & Cardiovasc Surg, Pittsburgh, PA USA
[3] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / 08期
关键词：
D O I：
10.1245/s10434-022-11584-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4686 / 4687
页数：2
相关论文
共 50 条
  • [1] A Randomized, Phase III Study of Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) in High-Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC)
    Martha E. Teke
    Amber Leila Sarvestani
    Jonathan M. Hernandez
    Hiran C. Fernando
    Robert D. Timmerman
    Annals of Surgical Oncology, 2022, 29 : 4686 - 4687
  • [2] Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with Stage I non-small-cell lung cancer?
    Mahmood, Sarah
    Bilal, Haris
    Faivre-Finn, Corinne
    Shah, Rajesh
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2013, 17 (05) : 845 - 853
  • [3] Lobectomy versus Stereotactic Ablative Radiotherapy (SABR) for Stage I Non Small Cell Lung Cancer (NSCLC) in 182 Patients
    Scotti, Vieri
    Simontacchi, Gabriele
    Furfaro, Ilaria Francesca
    Scartoni, Daniele
    Gonfiotti, Alessandro
    Viggiano, Domenico
    Cardillo, Carla De Luca
    Ferrari, Katia
    Agresti, Benedetta
    Zei, Giacomo
    Perna, Marco
    Bastiani, Paolo
    Bruni, Alessio
    Voltolini, Luca
    Livi, Lorenzo
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S675 - S675
  • [4] CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)
    Leschenko, Y.
    Chebotareva, T.
    Spizhenko, N.
    Fedusenko, A.
    Sharaevskiy, O.
    Buryk, V.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S39 - S39
  • [5] Outcome of stereotactic ablative radiotherapy (SABR) in early stage non-small cell lung cancer (NSCLC)
    Islam, Mohammad
    Cyriac, Abby
    Durga, Tarun
    Sarkodie, Thomas
    Begum, Gulshad
    Evans, Joanne
    Palvai, Sreekanth
    Tun, Khin
    LUNG CANCER, 2023, 178 : S55 - S55
  • [6] Stereotactic Ablative Radiotherapy (SABR) in Potentially Operable Patients with Stage I Non-small Cell Lung Cancer
    Lagerwaard, F. J.
    Verstegen, N. E.
    Haasbeek, C. J. A.
    Slotman, B. J.
    Smit, E. F.
    Paul, M. A.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S79 - S80
  • [7] STEREOTACTIC ABLATIVE RADIOTHERAPY (SABR) IN POTENTIALLY OPERABLE STAGE I NON-SMALL CELL LUNG CANCER PATIENTS
    Lagerwaard, Frank J.
    Verstegen, Naomi E.
    Haasbeek, Cornelis J.
    Slotman, Ben
    Paul, M. A.
    Smit, Egbert F.
    Senan, Suresh
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S278 - S279
  • [8] Outcome after stereotactic radiotherapy in 'high-risk' patients with stage I non-small cell lung cancer (NSCLC)
    Lagerwaard, F. J.
    Haasbeek, C. J. A.
    Smit, E. F.
    Slotman, B. J.
    Senan, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S87 - S88
  • [9] Stereotactic Ablative Radiotherapy (SABR) for Non-Small Cell Lung Cancer
    Iyengar, Puneeth
    Westover, Kenneth
    Timmerman, Robert D.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 34 (06) : 845 - 854
  • [10] Curative Treatment Rates and Use of Stereotactic Ablative Radiotherapy (SABR) for Stage I Non-small Cell Lung Cancer (NSCLC) in England
    Harden, S.
    CLINICAL ONCOLOGY, 2018, 30 (06) : E50 - E50
12345